Michael E. Prevoznik, SVP & General Counsel at QUEST DIAGNOSTICS INC (DGX), sold 7,232 shares at $206.21 ($1.5M) on 2026-03-05, disclosed to the SEC on 2026-03-06.
Scheduled sale ($1.5M) by SVP & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $204.86 | 3,354 | $687K | 46.2% |
| 2 | $206.21 | 3,878 | $800K | 53.8% |
| Total | $205.58 avg | 7,232 | $1.5M | 100% |
| Filing → |
| DGX | SELL | 2026-02-20 | $228K | — | Filing → |
| DGX | SELL | 2025-09-30 | $43K | — | Filing → |
| DGX | SELL | 2025-09-25 | $10.6M | — | Filing → |